You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

beta secretase

Showing 1 - 25 of 3,032
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Desmoid Tumors, Aggressive Fibromatosis Trial run by the NCI (PF-03084014)

Active, not recruiting
Has Results
  • Desmoid Tumors
  • Aggressive Fibromatosis
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 14, 2022

Gut Microbiome and Blood Indices in AD and Their Spousal

Recruiting
  • Alzheimer Disease
  • Gut Biome
    • Charlottesville, Virginia
      University of Virginia
    Jan 18, 2023

    Alzheimer Trial in Worldwide (JNJ-54861911, 10 mg, JNJ-54861911, 25 mg, Placebo)

    Terminated
    Has Results
    • Alzheimer Disease
    • JNJ-54861911, 10 mg
    • +3 more
    • Gent, Belgium
    • +16 more
    Jun 9, 2022

    Ovarian Granulosa-Stromal Tumor, Ovarian Granulosa Cell Tumor, Ovarian Cancer Trial in Canada, Poland, United States

    Recruiting
    • Ovarian Granulosa-Stromal Tumor
    • +2 more
    • Los Angeles, California
    • +20 more
    Jul 13, 2022

    Alzheimer's Disease (Incl Subtypes), Dementia Trial in Boston (MIB-626, Placebo)

    Recruiting
    • Alzheimer's Disease (Incl Subtypes)
    • Dementia
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Jul 11, 2022

    End-Stage Kidney Disease, End-Stage Renal Disease Trial in Boston, Minneapolis, New York (Metoprolol Succinate, Carvedilol)

    Not yet recruiting
    • End-Stage Kidney Disease
    • End-Stage Renal Disease
    • Boston, Massachusetts
    • +4 more
    Jun 26, 2023

    Stable Ischemic Heart Disease, Coronary Artery Disease, Beta-blocker Therapy Trial in Edmonton (Medical Assessment, Quality of

    Recruiting
    • Stable Ischemic Heart Disease
    • +2 more
    • Medical Assessment
    • Quality of Life Assessment
    • Edmonton, Alberta, Canada
      University of Alberta Hospital
    Jan 30, 2023

    Bone Denisty Change in Children With Beta Thalassemia Major

    Not yet recruiting
    • Evaluate Bone Denisty Changes in Children With Beta Thalassemia Major
    • Dexa scan
    • (no location specified)
    Sep 29, 2023

    Pediatric Hearing Loss Due to OTOF, GJB2, or GJB2/GJB6 Mutations

    Not yet recruiting
    • Congenital Hearing Loss Secondary to Biallelic Mutations in the Otoferlin Gene (OTOF)
    • +2 more
      • (no location specified)
      Aug 25, 2023

      Spleen Stiffness asMeasure to Assess REsponse to ß Blocker

      Not yet recruiting
      • High Risk Esophageal Varices
      • No intervention
      • New Delhi, Delhi, India
        Institute of Liver & Biliary Sciences
      Sep 16, 2023

      Cirrhosis, Liver, Portal Hypertension, Variceal Hemorrhage Trial in London (Carvedilol, Placebo)

      Recruiting
      • Cirrhosis, Liver
      • +3 more
      • London, United Kingdom
        King's College Hospital
      May 23, 2023

      type1diabetes, Type2diabetes, Pre Diabetes Trial in Parma (68Ga-exendin-4, mixed meal test)

      Recruiting
      • type1diabetes
      • +3 more
      • Parma, Pr, Italy
        Azienda Ospedaliero Universitaria di Parma
      Dec 20, 2022

      Diabetes, Type 2, Obesity Trial in Toronto (Time restricted feeding, Standard lifestyle)

      Recruiting
      • Diabetes Mellitus, Type 2
      • Obesity
      • Time restricted feeding
      • Standard lifestyle
      • Toronto, Ontario, Canada
        Leadership Sinai Centre foe Diabetes - Mount Sinai Hospital
      Jan 30, 2023

      Alzheimer's Disease Trial in Berlin, Ulm (Epigallocatechin-Gallate, Placebo)

      Completed
      • Alzheimer's Disease
      • Berlin, Germany
      • +2 more
      Jul 28, 2021

      Type 1 Diabetes Trial in Nijmegen (68Ga-NODAGA-Exendin-4)

      Recruiting
      • Type 1 Diabetes
      • Nijmegen, Gelderland, Netherlands
        Radboud University Medical Center
      Nov 17, 2022

      Pancreatic Ductal Adenocarcinoma, Gastroesophageal Adenocarcinoma, Glioblastoma Multiforme Trial (68Ga-FF58, 177Lu-FF58)

      Not yet recruiting
      • Pancreatic Ductal Adenocarcinoma
      • +2 more
      • (no location specified)
      Jul 28, 2023

      Aortic Valve Stenosis Trial (Beta blocker)

      Not yet recruiting
      • Aortic Valve Stenosis
      • Beta blocker
      • (no location specified)
      Feb 14, 2023

      Thalassemia, Beta Trial in Karachi (Hydroxyurea and Thalidomide)

      Completed
      • Thalassemia, Beta
      • Hydroxyurea and Thalidomide
      • Karachi, Sindh, Pakistan
        Children's Hospital Karachi
      Nov 23, 2023

      Fabry Disease Trial in Seoul (Fabagal® (Agalsidase beta), Active comparator (Agalsidase beta))

      Recruiting
      • Fabry Disease
      • Fabagal® (Agalsidase beta)
      • Active comparator (Agalsidase beta)
      • Seoul, Songpa-gu, Korea, Republic of
        Seoul Asan Center
      Oct 10, 2023

      Multiple Sclerosis, Relapsing-Remitting Trial in Worldwide (Dimethyl Fumarate, Peginterferon Beta-1a, Placebo)

      Terminated
      • Multiple Sclerosis, Relapsing-Remitting
      • Dimethyl Fumarate
      • +2 more
      • Raleigh, North Carolina
      • +22 more
      Nov 30, 2022

      Cognitive Function, Fatigue and Health Related Quality of Life

      Recruiting
      • Cognitive Change
      • +3 more
        • Giza, Egypt
          Abo El-Rish Pediatric Hospital
        Jul 20, 2022

        PreDiabetes, Hyperglycemia Trial in Nottingham, Birmingham (Beta-alanine, Placebo)

        Recruiting
        • Prediabetes
        • +2 more
        • Beta-alanine
        • Placebo
        • Nottingham, Nottinghamshire, United Kingdom
        • +1 more
        Dec 19, 2022

        Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

        Recruiting
        • Advanced Triple-Negative Breast Carcinoma
        • +4 more
        • Biopsy
        • +4 more
        • Birmingham, Alabama
        • +9 more
        Aug 31, 2022

        Fabry Disease Trial in Taipei

        Recruiting
        • Fabry Disease
          • Taipei, Taiwan
            Investigational Site Number :1580001
          Sep 24, 2023

          Bacterial Infections Trial in Adelaide (QPX2015, Placebo oral capsule)

          Completed
          • Bacterial Infections
          • Adelaide, South Australia, Australia
            CMAX
          Oct 6, 2022